NO20061626L - Tienopyrazoler - Google Patents

Tienopyrazoler

Info

Publication number
NO20061626L
NO20061626L NO20061626A NO20061626A NO20061626L NO 20061626 L NO20061626 L NO 20061626L NO 20061626 A NO20061626 A NO 20061626A NO 20061626 A NO20061626 A NO 20061626A NO 20061626 L NO20061626 L NO 20061626L
Authority
NO
Norway
Prior art keywords
tienopyrazoler
thienopyrazoles
itk
inhibition
modulated
Prior art date
Application number
NO20061626A
Other languages
English (en)
Norwegian (no)
Inventor
John G Jurcak
Philip Marvin Weintraub
Michael Louis Edwards
Ramalinga M Dharanipragada
Matthicu Barrague
Timothy Alan Gillespy
Kwon Yon Musick
Yan Du
Ashfaq Ahmed Parkar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20061626L publication Critical patent/NO20061626L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20061626A 2003-09-08 2006-04-10 Tienopyrazoler NO20061626L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08
PCT/US2004/023814 WO2005026175A1 (fr) 2003-09-08 2004-07-23 Thienopyrazoles

Publications (1)

Publication Number Publication Date
NO20061626L true NO20061626L (no) 2006-04-10

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061626A NO20061626L (no) 2003-09-08 2006-04-10 Tienopyrazoler

Country Status (29)

Country Link
US (2) US7518000B2 (fr)
JP (1) JP4879739B2 (fr)
KR (1) KR20060069490A (fr)
CN (1) CN100398545C (fr)
AT (1) ATE468341T1 (fr)
AU (1) AU2004272507B2 (fr)
BR (1) BRPI0414215A (fr)
CA (1) CA2538032C (fr)
CR (1) CR8255A (fr)
DE (1) DE602004027288D1 (fr)
DK (1) DK1682553T3 (fr)
EC (1) ECSP066411A (fr)
ES (1) ES2345257T3 (fr)
HR (1) HRP20100398T1 (fr)
IL (1) IL173916A (fr)
MA (1) MA28038A1 (fr)
ME (1) MEP20908A (fr)
MX (1) MXPA06001827A (fr)
MY (1) MY144339A (fr)
NO (1) NO20061626L (fr)
NZ (1) NZ545421A (fr)
OA (1) OA13252A (fr)
PT (1) PT1682553E (fr)
RS (2) RS51846B (fr)
RU (1) RU2358978C2 (fr)
TN (1) TNSN06058A1 (fr)
TW (1) TWI352705B (fr)
WO (1) WO2005026175A1 (fr)
ZA (1) ZA200601947B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (fr) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Derives du benzothiophene: preparation et applications pharmaceutiques
WO2007076228A2 (fr) * 2005-12-20 2007-07-05 Boehringer Ingelheim International Gmbh Inhibiteurs de kinases tec
EP2151433A1 (fr) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles et leur procédé de préparation
EP2151434A1 (fr) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles et leur procédé de préparation
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (fr) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Composés tricycliques à titre d'inhibiteurs de kinases tec
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
TW201414734A (zh) 2012-07-10 2014-04-16 Takeda Pharmaceutical 氮雜吲哚衍生物
WO2014041518A1 (fr) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Composés thiénopyrrole comme inhibiteurs de l'itk
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
EP3060218A4 (fr) 2013-10-25 2017-07-19 Pharmacyclics LLC Méthodes de traitement et de prévention d'une maladie du greffon contre l'hôte
AR099052A1 (es) 2014-01-09 2016-06-29 Takeda Pharmaceuticals Co Derivados de azaindol
WO2016010108A1 (fr) * 2014-07-18 2016-01-21 塩野義製薬株式会社 Dérivés hétérocycliques contenant de l'azote et compositions médicinales le contenant
HK1256718A1 (zh) 2015-08-31 2019-10-04 药品循环有限责任公司 用於治疗多发性骨髓瘤的btk抑制剂组合
US20190298772A1 (en) 2016-11-03 2019-10-03 Juno Therapeutics, Inc. Combination therapy of a t cell-based therapy and a btk inhibitor
EP3787751A1 (fr) 2018-05-03 2021-03-10 Juno Therapeutics, Inc. Polythérapie d'une thérapie par lymphocytes t à récepteur antigénique chimérique (car) et d'un inhibiteur de btk
WO2023139248A1 (fr) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibiteurs de thioestérases de protéine acyle contre des infections microbiennes
US20250302954A1 (en) 2022-05-11 2025-10-02 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
WO2024123175A1 (fr) 2022-12-06 2024-06-13 Erasmus University Medical Center Rotterdam Compositions pour le traitement de cancers résistants à la thérapie par blocage de point de contrôle immunitaire

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
PT1194425E (pt) * 1999-06-23 2005-10-31 Aventis Pharma Gmbh Benzimidazoles substituidos
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US7101884B2 (en) * 2001-09-14 2006-09-05 Merck & Co., Inc. Tyrosine kinase inhibitors
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
MXPA04003954A (es) * 2001-10-26 2004-11-29 Aventis Pharma Inc Bencimidazoles.

Also Published As

Publication number Publication date
JP4879739B2 (ja) 2012-02-22
PT1682553E (pt) 2010-07-29
HRP20100398T1 (hr) 2010-09-30
IL173916A (en) 2011-07-31
RU2358978C2 (ru) 2009-06-20
KR20060069490A (ko) 2006-06-21
US20070254937A1 (en) 2007-11-01
TW200519118A (en) 2005-06-16
RS51846B (sr) 2012-02-29
BRPI0414215A (pt) 2006-11-07
CN1849322A (zh) 2006-10-18
CA2538032A1 (fr) 2005-03-24
MEP20908A (en) 2010-06-10
ES2345257T3 (es) 2010-09-20
US7928231B2 (en) 2011-04-19
RU2006111470A (ru) 2007-10-27
TNSN06058A1 (en) 2007-10-03
CR8255A (es) 2006-07-14
ZA200601947B (en) 2007-05-30
DK1682553T3 (da) 2010-08-23
CN100398545C (zh) 2008-07-02
ECSP066411A (es) 2006-09-18
DE602004027288D1 (en) 2010-07-01
ATE468341T1 (de) 2010-06-15
CA2538032C (fr) 2011-01-11
IL173916A0 (en) 2006-07-05
AU2004272507B2 (en) 2011-05-12
JP2007505038A (ja) 2007-03-08
WO2005026175A1 (fr) 2005-03-24
OA13252A (en) 2007-01-31
HK1095587A1 (zh) 2007-05-11
AU2004272507A1 (en) 2005-03-24
RS20060162A (sr) 2008-06-05
TWI352705B (en) 2011-11-21
NZ545421A (en) 2010-03-26
MY144339A (en) 2011-08-29
US20100056514A1 (en) 2010-03-04
US7518000B2 (en) 2009-04-14
MXPA06001827A (es) 2006-05-31
MA28038A1 (fr) 2006-07-03

Similar Documents

Publication Publication Date Title
NO20061626L (no) Tienopyrazoler
ATE318812T1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
TW200801008A (en) Protein kinase inhibitors
ATE554087T1 (de) Neue kinaseinhibitoren
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
WO2004089286A3 (fr) Nouveaux composes et compositions utilises comme inhibiteurs de la proteine kinase
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
TR200102969T2 (tr) Siklik protein tirozin kinaz önleyicileri.
NO20070334L (no) 4,6-disubstituerte pyrimidiner og deres anvendelse som proteinkinaseinhibitorer
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
NO20054359L (no) Cykliske protein tyrosin kinase inhibitorer
MXPA05012596A (es) Inhibidores de quinasa, de indazol, bencisoxazol y bencisotiazol.
BRPI0616630B8 (pt) compostos de pirazol substituídos
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
WO2007067781A3 (fr) Inhibiteurs de proteines kinases
DE602004018780D1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
NO20072567L (no) Triazoler nyttige som proteinkinase-inhibitorer
EA200800546A1 (ru) Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk)
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
EA200801430A1 (ru) Производные триазола
DE602005015319D1 (de) Prodrugs von als erk-proteinkinase-inhibitoren wirkenden pyrrolylpyrimidinen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application